You are here

Revolutionizing Disease Prediction and Management through Plasma Lipidomic Profiling

Description 
A New Frontier in Healthcare: The era of one-size-fits-all medicine is giving way to a more tailored approach, where treatments and interventions are precisely tailored to the individual's unique genetic and metabolic makeup. This paradigm shift heralds a new era in combating cardiometabolic diseases, encompassing a spectrum of conditions such as cardiovascular disease (CVD), type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), and chronic kidney disease. Innovative Approach for Personalized Solutions: The Metabolomics Laboratory at the Baker Heart and Diabetes Institute is at the forefront of this transformative shift towards precision/personalized medicine. By harnessing the power of advanced lipidomic profiling – capable of measuring over 800 lipid species from a mere droplet of blood – we're pioneering the use of lipidomic signatures to uncover an individual’s susceptibility to disease onset and progression. Our mission is to harness the power of lipidomics to usher in a new era of precision medicine, where diagnosis and treatment are as unique as the patients themselves. Research Objective: 1. Advanced Lipidomic Profiling: Perform cutting-edge analysis of lipid profiles from human samples to illuminate the lipidomic landscape of cardiometabolic diseases. 2. Biomarker Discovery for Personalized Medicine: Identify and validate a spectrum of lipid biomarkers that pave the way for customized risk assessment and therapeutic strategies. 3. Development of Predictive Models: Craft predictive models that leverage lipidomic insights to forecast disease risk and progression, enabling proactive and personalized healthcare interventions. Your Role and Opportunities: In this groundbreaking project, you will be instrumental in driving forward the science of precision medicine through the lens of lipidomics. Your work will focus on identifying and validating novel lipid biomarkers. This crucial step is the backbone of personalized medicine, enabling the development of tailored diagnostic and therapeutic strategies. You will learn to navigate the complexities of biomarker research, from discovery through to validation. This involves applying bioinformatics and statistical analysis to translate raw data into actionable insights, a skill highly valued in both academic and industry settings. Why This Project? • Pioneering Role in Precision Medicine: Be at the forefront of a paradigm shift towards personalized care in cardiometabolic health. • Direct Impact: Your work will directly contribute to identifying new preventative and therapeutic avenues for cardiometabolic diseases. • Collaborative Excellence: Join a dynamic, multidisciplinary team at a world-class institution, with access to a broad network of national and international collaborators. Ideal Candidate: We are looking for passionate, driven individuals who are eager to make a difference in the field of precision medicine. The ideal candidate will possess: a keen analytical mind, capable of complex problem-solving and data analysis; excellent communication skills, with the ability to work effectively in a collaborative research environment; a commitment to advancing personalized healthcare through innovative research.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
precision medicine, biomarkers, risk assessment, bioinformatics, lipidomics
Available options 
PhD/Doctorate
Masters by research
Honours
Time commitment 
Full-time
Top-up scholarship funding available 
Yes
Year 1: 
$6000
Year 2: 
$6000
Year 3: 
$6000
Physical location 
Baker Heart and Diabetes Institute, Commercial Rd, Prahran.
Co-supervisors 
Dr 
Corey Giles
Prof 
Peter Meikle

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.